Table of Contents
The prevailing notion that THC potency is the primary determinant of value in cannabis products continues to hold sway among consumers, as reported by cannabis operators. This perspective, favoring higher levels of THC, remains a dominant factor influencing purchasing decisions in the cannabis market. However, there is a growing recognition of secondary factors that are beginning to shape genetics trends in cultivation facilities throughout the United States.
Beyond the quest for high-THC and high-yield cultivars, there is an expanding interest among consumers in more nuanced aspects of cannabis products. Industry experts are observing a shift in consumer preferences and market demands, highlighting several key areas of focus:
- Terpene Profiles:
- There is a growing awareness and curiosity among consumers regarding the terpene profiles in cannabis products. Terpenes, which are the compounds responsible for the aroma and flavor in cannabis, significantly impact the overall sensory experience of the product. Additionally, these compounds are thought to be key contributors to the entourage effect, which may amplify the therapeutic benefits of cannabis. In response to this increased interest, cultivators are focusing more on developing strains that feature unique and attractive terpene profiles.
- Legacy Strains Bred with High-THC Cultivars:
- There is a growing trend of breeding legacy, or classic, cannabis strains with newer, high-THC cultivars. This approach aims to combine the unique characteristics of traditional strains, often revered for their specific effects and flavor profiles, with the potent psychoactive effects of modern high-THC varieties. This hybridization seeks to cater to both nostalgic preferences and the desire for stronger effects.
- Minor Cannabinoids:
- There is a growing trend among consumers showing increased interest in lesser-known cannabinoids like tetrahydrocannabivarin (THCV) and cannabinol (CBN). These cannabinoids, though present in smaller quantities compared to THC and CBD, are being recognized for their unique effects and potential health benefits. THCV, for instance, is gaining attention for its purported energy-boosting and appetite-suppressing properties, while CBN is being explored for its potential as a sleep aid. Cultivators are increasingly experimenting with genetic breeding and cultivation techniques to enhance the levels of these minor cannabinoids in their strains.
In conclusion, while high THC potency continues to be a significant driver in the consumer market for cannabis products, there is a clear trend toward a more sophisticated understanding and appreciation of the plant’s diverse attributes. This shift is influencing the direction of genetic trends in cultivation facilities, as they strive to meet the evolving preferences of consumers. The cannabis industry is thus witnessing a broadening of focus, encompassing not only the pursuit of potency but also a deeper exploration of the plant’s aromatic, genetic, and cannabinoid diversity.
Despite emerging trends and the growing complexity of consumer preferences in the cannabis market, it is evident that THC potency continues to reign supreme as the most pivotal factor for consumers. This prevailing inclination towards high THC levels underscores the enduring appeal of strong psychoactive effects among a significant portion of the cannabis consumer base.
THC, also known as tetrahydrocannabinol, is the main psychoactive substance in cannabis that causes the ‘high’ sensation in users. Its potency in a cannabis product directly correlates with the intensity of this psychoactive effect, making it a crucial consideration for many consumers. For a substantial number of users, the strength of the high remains the benchmark for evaluating the quality and desirability of a cannabis product. This preference often guides their purchasing decisions, with higher THC percentages often equated with superior quality and value.
This ongoing emphasis on THC potency is not only evident in consumer behavior but also significantly influences the strategies and offerings of cultivators and retailers. Many cultivation facilities continue to focus heavily on breeding and cultivating strains that boast high levels of THC, in response to consistent market demand. Similarly, dispensaries and cannabis retailers often highlight THC percentages in their product displays and marketing materials, recognizing the potency as a key selling point for a large segment of their customer base.
Nevertheless, it’s crucial to acknowledge that the rising prominence of this trend doesn’t lessen the significance of other factors that are steadily becoming more important to consumers. While THC potency remains a primary concern, a growing number of users are showing interest in other aspects of cannabis, such as the flavor profiles imparted by different terpenes, the effects of various cannabinoid compositions, and the unique characteristics of heritage or hybrid strains.
Furthermore, as the cannabis market matures and diversifies, there is a burgeoning segment of consumers who are seeking experiences beyond just the strength of THC. These individuals are often more interested in the holistic effects of cannabis, the nuances of different strains, and the potential therapeutic benefits of lesser-known cannabinoids. This shift is gradually leading to a more nuanced cannabis marketplace, where THC potency is just one of many factors that consumers consider.
In conclusion, while THC potency continues to be a primary driver in the consumer cannabis market, the landscape is evolving. The market is gradually accommodating a wider range of preferences and interests, reflecting a growing sophistication in consumer understanding and appreciation of cannabis. As the industry progresses, this trend towards a more diverse and complex market will likely continue, with THC potency remaining important, but increasingly seen as one aspect of a multi-faceted cannabis experience.
Breeding Legacy Strains with High-THC Varieties
House of Kush is a pioneering establishment in the cannabis industry, dedicated to preserving and cultivating what are known as legacy genetics – these are cultivars with names that echo back to the prohibition era, carrying a sense of nostalgia and historical significance. Iconic strains such as Bubba Kush and OG Kush are prime examples of such genetics, resonating deeply with consumers who have a long-standing familiarity with the cannabis culture.
Joshua Harris, a spokesperson for House of Kush, elaborates on this trend, noting the enduring appeal of these time-honored strains. “Even though people love the legacy names and they love buying legacy strains, high THC is the rule of the day,” he observes. In response to this market trend, House of Kush has embarked on an innovative breeding program. They have begun to cross these beloved legacy strains with other genetically diverse strains known for their higher potency in THC. This approach is not only about enhancing the THC content but also about introducing a novel twist to these classic strains, thereby appealing to both traditionalists and those seeking a more potent cannabis experience.
The fusion of classic strains with high-THC cultivars represents not only an homage to cannabis history but also a pathway toward the future of its consumption. The resultant hybrids offer a unique combination of the familiar, comforting effects of the classic strains with the enhanced potency and experiential range of modern, high-THC varieties. This fusion brings a fresh perspective to these well-loved strains, adding an element of excitement and novelty for consumers, especially for those who seek a more robust experience from their cannabis products.
This trend is not isolated to House of Kush alone. Nathaniel “Nutta” Vereen, co-founder at Tical Official, a prominent New York-based cannabis brand with a presence in 11 states, echoes similar sentiments. “Legacy strains have been a big topic of discussion,” Vereen says, pointing out the resurgence and continued relevance of these strains in contemporary cannabis culture. He remarks on the popularity of strains like Blue Dream, which experienced a surge in demand and is now seeing a new chapter with efforts to cross it with new cultivars. This approach is indicative of a broader trend within the industry, where there is a growing interest in revisiting and reinvigorating classic strains through genetic experimentation and breeding.
In summary, the focus on legacy genetics by House of Kush and similar entities in the cannabis industry represents a significant trend. By blending the cherished and familiar legacy strains with higher THC cultivars, these pioneers are not only preserving a rich cannabis heritage but also catering to the evolving preferences of consumers. This blend of tradition and innovation is setting the stage for an exciting era in cannabis cultivation, offering consumers a diverse range of experiences and flavors.
Understanding Terpene Profiles
The cannabis industry continues to observe that consumers have a strong preference for products categorized under traditional labels such as indica, sativa, and hybrid, despite ongoing debates about the accuracy and meaningfulness of these classifications in predicting the effects of the products. Shai Ramsahai, the president of Barcelona points out this enduring trend. He notes, “After that, high THC is at the top of the list of important strain characteristics.” This statement underscores the significance of THC potency in consumer preferences.
Ramsahai, in his communication with MJBizDaily, elaborates further on the evolving interests of consumers, particularly in the United States. He emphasizes the growing focus on terpenes, which are the aromatic compounds in cannabis that not only give it its distinct scent and flavor but may also influence its effects. Specifically, U.S. consumers are showing a heightened interest in limonene and myrcene, two terpenes known for their distinctive aromas and presumed therapeutic benefits.
Echoing this sentiment is Baltimore-based Curio Wellness, a cannabis cultivator that prides itself on its sophisticated cultivation methods, including growing cannabis strains from tissue culture. Curio Wellness is committed to offering its consumers a diverse range of cultivars at various price points, carefully categorized into the traditional indica, hybrid, and sativa segments. Rebecca Raphael, Curio’s Chief Revenue Officer, explains their approach: “We always want to have something high in myrcene for the indica customers, something that has a more balanced bouquet of terpenes that are hybrid, and then limonene, pinene or terpinolene for the sativa strains.” This strategy reflects an understanding of consumer preferences and the nuances of terpene profiles.
Similarly, Big Island Grown, a vertically integrated cannabis operator based in Hawaii, places significant emphasis on both terpene diversity and cannabinoid content in its nursery operations. The company’s co-founder and CEO, Jaclyn Moore, shared with MJBizDaily their enthusiasm for tropical fruit terpenes, which is reflected in their product offerings. This year, Big Island Grown is set to launch strains with evocative names like Sunkissed, Papaya, and Guava Jelly. These names not only align with the brand’s identity but also indicate the presence of fruity terpene profiles in these strains.
Looking to the future, Moore expresses a hope that consumers will begin to appreciate the so-called “cheesy” strains, or cultivars that are rich in terpenes like terpinolene, ocimene, and myrcene. She believes these terpenes are “grossly underrated” and deserve more recognition for their unique qualities. “A lot of people can’t face the funk,” Moore adds, indicating that while some consumers may find the pungent aromas of these terpenes challenging, they offer a distinct and valuable experience.
In summary, while THC potency continues to be a critical factor for consumers, there is a growing interest in the terpene profiles of cannabis products. The trend is towards a more sophisticated understanding of how different terpenes influence the aroma, flavor, and potentially the effects of cannabis.
Potential of Lesser-Known Cannabinoids
The landscape of cannabinoid research is rapidly evolving, revealing a multitude of potential applications for various cannabinoids. This expanding body of knowledge is driving a surge in consumer interest toward minor cannabinoids, which are cannabinoids other than the well-known THC (tetrahydrocannabinol) and CBD (cannabidiol). These lesser-known compounds, such as CBN (cannabinol) and THCV (tetrahydrocannabivarin), are gaining recognition for their unique properties and potential health benefits.
Curio Wellness, a leader in cannabinoid research and product development, has gleaned valuable insights from patient trials regarding the effects of THCV. This particular cannabinoid has shown to be especially beneficial for consumers seeking to feel more focused and energized. Unlike the sometimes overwhelming psychoactive effects associated with high THC levels, THCV provides a more nuanced experience. Rebecca Raphael of Curio Wellness elaborates on the distinct qualities of THCV, noting that it offers a balanced feeling, combining psychoactivity with enhanced energy and focus. Curio Wellness has already introduced ingestible THCV tablets to the market, and this year, the company plans to broaden its offerings. They intend to introduce a proprietary genetic developed by Phylos BioScience, featuring a unique composition of approximately 18% THC and 14%-16% THCV. “You don’t get this big head high,” Raphael explained, emphasizing the balanced and focused effects of THCV.
On the other hand, CBN is also emerging as a popular cannabinoid among consumers, as noted by Jason Vedadi, founder and CEO of Arizona-based Story Cannabis Co. “The one that seems to resonate the most, where you’re seeing the category grow, is CBN,” Vedadi remarked. Though research into CBN is still in its infancy, its potential as a sleep aid is particularly intriguing to consumers. This interest is reflective of a broader trend in the cannabis market, where there is a growing appreciation for cannabinoids that offer specific health benefits or therapeutic effects.
Vedadi expressed excitement about the future of minor cannabinoid research, anticipating a wealth of new insights into their properties and uses. He foresees a future where cannabinoids could be used either individually or in combination with others to produce customized effects tailored to individual needs and preferences. “I think we’re at the cusp of that,” Vedadi said, highlighting the potential for groundbreaking developments in the application of minor cannabinoids.
In conclusion, ongoing research is increasingly revealing the varied uses and advantages of cannabinoids, leading to a growing consumer interest in lesser-known cannabinoids such as THCV and CBN. Pioneers in the field like Curio Wellness and Story Cannabis Co. are actively investigating these compounds and creating products tailored to meet specific consumer demands and tastes. This shift towards minor cannabinoids reflects a developing cannabis market that prioritizes customized and specific effects, setting the stage for novel products and treatments in the times ahead.
